Company will leverage recent financing and joint development agreement with electric aviation manufacturing partner to develop safer and more efficient...
Mission Launched via SpaceX CRS-31; Experiment Now Underway on the ISSCollaboration Aims to Enhance Healthspan on Earth and Improve Astronaut...
70-year-old patient with advanced chemo-refractory anal cancer achieves complete response (CR) in 8 weeks when treated with MDNA11 in combination...
CLEVELAND, Dec. 4, 2024 /PRNewswire/ -- Centerline Biomedical, Inc. ("Centerline"), an innovative leader in cardiovascular navigation and visualization systems, announced...
Solicitation now open for multiple awards supporting space-based tissue engineering and mechanobiology research KENNEDY SPACE CENTER, Fla., Dec. 4, 2024...
MORRISVILLE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Codetta Bio, a leader in integrated multi-omics solutions, is proud to announce...
Pivotal Phase 3 4WARD clinical trial is evaluating use of oral mavorixafor as monotherapy and in combination with injectable G-CSFBOSTON,...
With Cedar Pay, NAPA has streamlined the payment process and increased payments from patients with balances after insurance by 71%...
Focused Ultrasound Therapy for tremors is now available for patients with Dr. Taghva in Orange County MISSION VIEJO, CAPELLEN /...
Building on preclinical success demonstrating age reversal, longevity, and increased healthspan, Telomir-1 appears to address insulin resistance at its root,...
First program to result from end-to-end use of OS to identify a novel target and new chemical matter, which moved...
First three Single Ascending Dose cohorts demonstrated no treatment related adverse events Carlsbad, CA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Palisade...
6-month efficacy and safety data from ongoing Phase 1/2 trial of OPGx-LCA5 to be presentedFARMINGTON HILLS, Mich., Dec. 03, 2024...
SAN FRANCISCO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. (“Excision”, the “Company”), a biotechnology company developing CRISPR-based therapies...
VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (“Rakovina” or the “Company”), a biopharmaceutical...
SEATTLE, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to...
Five-year renewable agreement secures reliable cGMP rhenium-186 (Re-186) supply for late-stage clinical and commercial forecastsAUSTIN, Texas, Dec. 03, 2024 (GLOBE...
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that COMET-HF (Confirmation of...
Strategic appointment strengthens the company's technology leadership as it seeks to revolutionize cancer diagnostics BALTIMORE and PALO ALTO, Calif., Dec....
Artificial Intelligence Collaboration Showcased at RSNA 2024 CHICAGO, Dec. 2, 2024 /PRNewswire/ -- Fovia, Inc., a world leader in advanced...